1 active not recruiting, 1 recruiting, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Withdrawn 1 |
Follow Oct: new trials by email Literature Review of Oct trials Research Report on Oct
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations Pemigatinib, Computed Tomography (CT), Magnetic Resonance Imaging - Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma | Phase 2 | Recruiting | Sameek Roychowdhury | 40 | 2025-08-26 | 2026-02-17 |
| Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment Biospecimen Collection, Erdafitinib, Magnetic Resonance Imaging - Recurrent Glioma, Recurrent WHO Grade 2 Glioma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 30 | 2024-01-04 | 2026-10-15 |
| Restylane Silk for Treatment of Chest Wrinkles Restylane Silk, Saline, Optical Coherence Tomography - Wrinkle | Phase 2 | Withdrawn | Heidi Waldorf | 2018-01-28 | 2018-03-06 |
Glioma (1) · Pancreatic Neoplasms (1)
Heidi Waldorf (1) · National Cancer Institute (NCI) (1) · Sameek Roychowdhury (1)
United States (3)
Giselle Singer (1) · Heidi Waldorf, MD (1) · Sameek Roychowdhury, MD, PhD (1)
UM1CA186644 (1)